Truncated tau and Aβ cooperatively impair mitochondria in primary neurons

Neurobiology of Aging

Volumn 33, Issue 3, 2012, Pages 619.e25-619.e35

  Quintanilla, Rodrigo A ^a   Dolan, Philip J ^a,b   Jin, Youngnam N ^a   Johnson, Gail V W ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Alzheimer; A ; Caspase; Mitochondria; Oxidative stress; Tau

Indexed keywords

AMYLOID A PROTEIN; AMYLOID BETA PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; BRAIN CELL; BRAIN MITOCHONDRION; CELL VIABILITY; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOCHONDRION SWELLING; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION;

EID: 84855761078     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.02.007     Document Type: Article

References (35)

1. Blass J.P., Gibson G.E., Hoyer S. The role of the metabolic lesion in Alzheimer's disease. J. Alzheimers Dis 2002, 4:225-232.
2. Brennan A.M., Wong S.W., Won S.J., Narasimhan P., Kauppinen T.M., Lee H., Edling Y., Chan P.H., Swanson R.A. NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat. Neurosci 2009, 12:857-863.
3. Chung C.W., Song Y.H., Kim I.K., Yoon W.J., Ryu B.R., Jo D.G., Woo H.N., Kwon Y.K., Kim H.H., Gwang B.J., Mook-Jung I.H., Jung Y.K. Proapoptotic effects of tau cleavage product generated by caspase-3. Neurobiol. Dis 2001, 8:162-172.
4. de Calignon A., Fox L.M., Pitstick R., Carlson G.A., Bacskai B.J., Spires-Jones T.L., Hyman B.T. Caspase activation precedes and leads to tangles. Nature 2010, 464:1201-1204.
5. Dong-Hyung C., Nakamura T., Fang J., Ciepak P., Godzik A., Gu Z., Lipton S.A. S-nitrosylation of Drp1 mediates b-amyloid-related mitochondrial fission and neuronal injury. Science 2009, 324:102-105.
6. Du H., Guo L., Fang F., Chen D., Sosunov A.A., McKhann G.M., Yan Y., Wang C.H., Zhang H., Molkentin J.D., Gunn-Moore F.J., Vonsattel J.P., Arancio O., Chen J.X., Yan S.D. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat. Med 2008, 10:1097-1105.
7. Falzone T.L., Gunawardena S., McClearly D., Reis G.F., Goldstein L.S.B. Kinesin-1 transport reductions enchance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopaties. Hum. Mol. Genet 2010, 19:4399-4408.
8. Gamblin T.C., Chen F., Zambrano A., Abraha A., Lagalwar S., Guillozet A.L., Lu M., Fu Y., García-Sierra F., LaPointe N., Miller R., Berry R.W., Binder L.I., Cryns V.L. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:10032-10037.
9. García-Sierra F., Mondragón-Rodríguez S., Basurto-Islas G. Truncation of tau protein and its pathological significance in Alzheimer's disease. J. Alzheimers Dis. 2008, 14:401-409.
10. Gibson G.E., Shi Q. A mitocentric view of Alzheimer's disease suggests multi-faceted treatments. J. Alzheimers Dis. 2010, 20(Suppl. 2):S591-S607.
11. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:4913-4917.
12. Hanger D.P., Anderton B.H., Noble W. Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol. Med 2009, 15:112-119.
13. Hernández F., Avila J. Tau aggregates and tau pathology. J. Alzheimers Dis. 2008, 14:449-452.
14. Krishnamurthy P.K., Johnson G.V. Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model. J. Biol. Chem 2004, 279:7893-78900.
15. Kosik K.S., Joachim C.L., Selkoe D.J. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:4044-4048.
16. Li Z., Jo J., Jia J.M., Lo S.C., Whitcomb D.J., Jiao S., Cho K., Sheng M. Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell 2010, 141:859-871.
17. Mandelkow E.M., Stamer K., Vogel R., Thies E., Mandelkow E. Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiol. Aging 2003, 24:1079-1085.
18. Matthews-Roberson T.A., Quintanilla R.A., Ding H., Johnson G.V. Immortalized cortical neurons expressing caspase-cleaved tau are sensitized to endoplasmic reticulum stress induced cell death. Brain Res. 2008, 1234:206-212.
19. Miller K., Sheetz M.P. Axonal mitochondrial transport and potential are correlated. J. Cell Biol 2004, 117:2791-2804.
20. Quintanilla R.A., Matthews-Roberson T.A., Dolan P.J., Johnson G.V. Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: Implications for the pathogenesis of Alzheimer disease. J. Biol. Chem 2009, 284:18754-18766.
21. Quintanilla R.A., Muñoz F.J., Metcalfe M.J., Hitschfeld M., Olivares G., Godoy J.A., Inestrosa N.C. Trolox and 17beta-estradiol protect against amyloid beta-peptide neurotoxicity by a mechanism that involves modulation of the Wnt signaling pathway. J. Biol. Chem. 2005, 280:11615-11625.
22. Rhein V., Song X., Wiesner A., Ittner L.M., Baysang G., Meier F., Ozmen L., Bluethmann H., Dröse S., Brandt U., Savaskan E., Czech C., Götz J., Eckert A. Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20057-20062.
23. Rissman R.A., Poon W.W., Blurton-Jones M., Oddo S., Torp R., Vitek M.P., LaFerla F.M., Rohn T.T., Cotman C.W. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J. Clin. Invest 2004, 114:121-130.
24. Santacruz K., Lewis J., Spires T., Paulson J., Kotilinek L., Ingelsson M., Guimaraes A., DeTure M., Ramsden M., McGowan E., Forster C., Yue M., Orne J., Janus C., Mariash A., Kuskowski M., Hyman B., Hutton M., Ashe K.H. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005, 309:476-481.
25. Santos M.J., Quintanilla R.A., Toro A., Grandy R., Dinamarca M.C., Godoy J.A., Inestrosa N.C. Peroxisomal proliferation protects from beta-amyloid neurodegeneration. J. Biol. Chem 2005, 280:41057-41068.
26. Shah S.B., Nolan R., Davis E., Stokin G.B., Niesman I., Canto I., Glabe C., Goldstein L.S. Examination of potential mechanisms of amyloid-induced defects in neuronal transport. Neurobiol. Dis 2009, 36:11-25.
27. Small S.A., Duff K. Linking Aβ and tau in late-onset Alzheimer's disease: a dual pathway hypothesis. Neuron 2008, 60:534-542.
28. Spires-Jones T.L., de Calignon A., Matsui T., Zehr C., Pitstick R., Wu H.Y., Osetek J.D., Jones P.B., Bacskai B.J., Feany M.B., Carlson G.A., Ashe K.H., Lewis J., Hyman B.T. In vivo imaging reveals dissociation between caspase activation and acute neuronal death in tangle-bearing neurons. J. Neurosci 2008, 28:862-867.
29. Stamer K., Vogel R., Thies E., Mandelkow E., Mandelkow E.M. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol 2002, 156:1051-1063.
30. Stoothoff W., Jones P.B., Spires-Jones T.L., Joyner D., Chhabra E., Bercury K., Fan Z., Xie H., Bacskai B.J., Irimia D., Hyman B.T. Differential effect of three-repeat and four-repeat tau on mitochondrial axonal transport. J. Neurochem 2009, 111:417-427.
31. Thies E., Mandelkow E.M. Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1. J. Neurosci 2007, 27:2896-2907.
32. Wang X., Su B., Siedlak S.L., Moreira P.I., Fujioka H., Wang Y., Casadesus G., Zhu X. Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:19318-19323.
33. Wang X., Su B., Lee H.G., Li X., Perry G., Smith M.A., Zhu X. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J. Neurosci 2009, 29:9090-9103.
34. Yao J., Irwin R., Zhao L., Nilsen J., Hamilton R.T., Diaz-Brinton R. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2009, 34:14670-14675.
35. Vossel K.A., Zhang K., Brodbeck J., Daub A.C., Sharma P., Finkbeiner S., Cui B., Mucke L. Tau reduction prevents Abeta-induced defects in axonal transport. Science 2010, 330:198.